Oncohema Key

Chemotherapy Classification system Number of patients Favourable response rates (%) Progression-free survival (%) Conclusion First author BEP × 4 Indiana University 159 73 61 Double-dose cisplatin not superior and more toxic Nichols…

Treatment option USA (N:261)a (%) Europe (N:969) (%) RAD Chemotherapy Surveillance Several options 62b 3b 21b 19 21 18 42 Vossen et al. [32] Arvold et al. [31] aCompliance rate,…